Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression.
Stahl
Stephen M
SM
Neuroscience Education Institute in Carlsbad, California, USA.
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000628:therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000627:therapeutic use; D055502:Secondary Prevention; D013763:Tetrahydrofolates / Q000627:therapeutic use; D016896:Treatment Outcome
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D013763:Tetrahydrofolates; D005492:Folic Acid; C005984:5-methyltetrahydrofolate